ArticleBMC neurology2026

BRAF-amplified glioblastoma patients have a worse prognosis than those with BRAF mutation and are associated with amplification of MET, RHEB and CUL1.

Rong Da et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.